Global Biosimilar Testing and Development Services Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03240175

Publication Date:

March 1, 2024

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Biosimilar Testing and Development Services market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Testing and Development Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Testing and Development Services market. Biosimilar Testing and Development Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Testing and Development Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Testing and Development Services market.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
Key Features:
The report on Biosimilar Testing and Development Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Testing and Development Services market. It may include historical data, market segmentation by Type (e.g., Effector Binding, ELISA), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Testing and Development Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Testing and Development Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Testing and Development Services industry. This include advancements in Biosimilar Testing and Development Services technology, Biosimilar Testing and Development Services new entrants, Biosimilar Testing and Development Services new investment, and other innovations that are shaping the future of Biosimilar Testing and Development Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Testing and Development Services market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Testing and Development Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Testing and Development Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Testing and Development Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Testing and Development Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Testing and Development Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Testing and Development Services market.
Market Segmentation:
Biosimilar Testing and Development Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Segmentation by application
PK assay
Tiered Immunogenicity testing
NAb assays
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Testing and Development Services Market Size 2019-2030
2.1.2 Biosimilar Testing and Development Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biosimilar Testing and Development Services Segment by Type
2.2.1 Effector Binding
2.2.2 ELISA
2.2.3 Kinetic Binding Assays
2.2.4 ADCC & CDC Cell-Based Assays
2.3 Biosimilar Testing and Development Services Market Size by Type
2.3.1 Biosimilar Testing and Development Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilar Testing and Development Services Market Size Market Share by Type (2019-2024)
2.4 Biosimilar Testing and Development Services Segment by Application
2.4.1 PK assay
2.4.2 Tiered Immunogenicity testing
2.4.3 NAb assays
2.5 Biosimilar Testing and Development Services Market Size by Application
2.5.1 Biosimilar Testing and Development Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilar Testing and Development Services Market Size Market Share by Application (2019-2024)
3 Biosimilar Testing and Development Services Market Size by Player
3.1 Biosimilar Testing and Development Services Market Size Market Share by Players
3.1.1 Global Biosimilar Testing and Development Services Revenue by Players (2019-2024)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2019-2024)
3.2 Global Biosimilar Testing and Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilar Testing and Development Services by Regions
4.1 Biosimilar Testing and Development Services Market Size by Regions (2019-2024)
4.2 Americas Biosimilar Testing and Development Services Market Size Growth (2019-2024)
4.3 APAC Biosimilar Testing and Development Services Market Size Growth (2019-2024)
4.4 Europe Biosimilar Testing and Development Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Biosimilar Testing and Development Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biosimilar Testing and Development Services Market Size by Country (2019-2024)
5.2 Americas Biosimilar Testing and Development Services Market Size by Type (2019-2024)
5.3 Americas Biosimilar Testing and Development Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Testing and Development Services Market Size by Region (2019-2024)
6.2 APAC Biosimilar Testing and Development Services Market Size by Type (2019-2024)
6.3 APAC Biosimilar Testing and Development Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilar Testing and Development Services by Country (2019-2024)
7.2 Europe Biosimilar Testing and Development Services Market Size by Type (2019-2024)
7.3 Europe Biosimilar Testing and Development Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Testing and Development Services by Region (2019-2024)
8.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biosimilar Testing and Development Services Market Forecast
10.1 Global Biosimilar Testing and Development Services Forecast by Regions (2025-2030)
10.1.1 Global Biosimilar Testing and Development Services Forecast by Regions (2025-2030)
10.1.2 Americas Biosimilar Testing and Development Services Forecast
10.1.3 APAC Biosimilar Testing and Development Services Forecast
10.1.4 Europe Biosimilar Testing and Development Services Forecast
10.1.5 Middle East & Africa Biosimilar Testing and Development Services Forecast
10.2 Americas Biosimilar Testing and Development Services Forecast by Country (2025-2030)
10.2.1 United States Biosimilar Testing and Development Services Market Forecast
10.2.2 Canada Biosimilar Testing and Development Services Market Forecast
10.2.3 Mexico Biosimilar Testing and Development Services Market Forecast
10.2.4 Brazil Biosimilar Testing and Development Services Market Forecast
10.3 APAC Biosimilar Testing and Development Services Forecast by Region (2025-2030)
10.3.1 China Biosimilar Testing and Development Services Market Forecast
10.3.2 Japan Biosimilar Testing and Development Services Market Forecast
10.3.3 Korea Biosimilar Testing and Development Services Market Forecast
10.3.4 Southeast Asia Biosimilar Testing and Development Services Market Forecast
10.3.5 India Biosimilar Testing and Development Services Market Forecast
10.3.6 Australia Biosimilar Testing and Development Services Market Forecast
10.4 Europe Biosimilar Testing and Development Services Forecast by Country (2025-2030)
10.4.1 Germany Biosimilar Testing and Development Services Market Forecast
10.4.2 France Biosimilar Testing and Development Services Market Forecast
10.4.3 UK Biosimilar Testing and Development Services Market Forecast
10.4.4 Italy Biosimilar Testing and Development Services Market Forecast
10.4.5 Russia Biosimilar Testing and Development Services Market Forecast
10.5 Middle East & Africa Biosimilar Testing and Development Services Forecast by Region (2025-2030)
10.5.1 Egypt Biosimilar Testing and Development Services Market Forecast
10.5.2 South Africa Biosimilar Testing and Development Services Market Forecast
10.5.3 Israel Biosimilar Testing and Development Services Market Forecast
10.5.4 Turkey Biosimilar Testing and Development Services Market Forecast
10.5.5 GCC Countries Biosimilar Testing and Development Services Market Forecast
10.6 Global Biosimilar Testing and Development Services Forecast by Type (2025-2030)
10.7 Global Biosimilar Testing and Development Services Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Information
11.1.2 Eurofins Scientific Biosimilar Testing and Development Services Product Offered
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eurofins Scientific Main Business Overview
11.1.5 Eurofins Scientific Latest Developments
11.2 SGS
11.2.1 SGS Company Information
11.2.2 SGS Biosimilar Testing and Development Services Product Offered
11.2.3 SGS Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 SGS Main Business Overview
11.2.5 SGS Latest Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Biosimilar Testing and Development Services Product Offered
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Charles River Laboratories Main Business Overview
11.3.5 Charles River Laboratories Latest Developments
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Information
11.4.2 Pharmaceutical Product Development Biosimilar Testing and Development Services Product Offered
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pharmaceutical Product Development Main Business Overview
11.4.5 Pharmaceutical Product Development Latest Developments
11.5 Exova
11.5.1 Exova Company Information
11.5.2 Exova Biosimilar Testing and Development Services Product Offered
11.5.3 Exova Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Exova Main Business Overview
11.5.5 Exova Latest Developments
11.6 Source BioScience
11.6.1 Source BioScience Company Information
11.6.2 Source BioScience Biosimilar Testing and Development Services Product Offered
11.6.3 Source BioScience Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Source BioScience Main Business Overview
11.6.5 Source BioScience Latest Developments
11.7 Intertek Group
11.7.1 Intertek Group Company Information
11.7.2 Intertek Group Biosimilar Testing and Development Services Product Offered
11.7.3 Intertek Group Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Intertek Group Main Business Overview
11.7.5 Intertek Group Latest Developments
11.8 Medistri
11.8.1 Medistri Company Information
11.8.2 Medistri Biosimilar Testing and Development Services Product Offered
11.8.3 Medistri Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Medistri Main Business Overview
11.8.5 Medistri Latest Developments
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Information
11.9.2 Pace Analytical Services Biosimilar Testing and Development Services Product Offered
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pace Analytical Services Main Business Overview
11.9.5 Pace Analytical Services Latest Developments
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Information
11.10.2 Sigma-Aldrich Biosimilar Testing and Development Services Product Offered
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sigma-Aldrich Main Business Overview
11.10.5 Sigma-Aldrich Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂